Correlation Between Scpharmaceuticals and MBX Biosciences,
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and MBX Biosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and MBX Biosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and MBX Biosciences, Common, you can compare the effects of market volatilities on Scpharmaceuticals and MBX Biosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of MBX Biosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and MBX Biosciences,.
Diversification Opportunities for Scpharmaceuticals and MBX Biosciences,
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scpharmaceuticals and MBX is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and MBX Biosciences, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MBX Biosciences, Common and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with MBX Biosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MBX Biosciences, Common has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and MBX Biosciences, go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and MBX Biosciences,
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the MBX Biosciences,. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.92 times less risky than MBX Biosciences,. The stock trades about -0.05 of its potential returns per unit of risk. The MBX Biosciences, Common is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,600 in MBX Biosciences, Common on August 27, 2024 and sell it today you would earn a total of 250.00 from holding MBX Biosciences, Common or generate 15.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 28.19% |
| Values | Daily Returns |
Scpharmaceuticals vs. MBX Biosciences, Common
Performance |
| Timeline |
| Scpharmaceuticals |
| MBX Biosciences, Common |
Scpharmaceuticals and MBX Biosciences, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and MBX Biosciences,
The main advantage of trading using opposite Scpharmaceuticals and MBX Biosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, MBX Biosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MBX Biosciences, will offset losses from the drop in MBX Biosciences,'s long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| MBX Biosciences, vs. Eliem Therapeutics | MBX Biosciences, vs. HCW Biologics | MBX Biosciences, vs. Scpharmaceuticals | MBX Biosciences, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |